Multi-Target Drugs Against Metabolic Disorders

Author(s): Luciana Scotti*, Marcus T. Scotti.

Journal Name: Endocrine, Metabolic & Immune Disorders - Drug Targets
(Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders)

Volume 19 , Issue 4 , 2019

Become EABM
Become Reviewer

Congenital anomalies fact sheet updated September 2016 (Accessed December 2017).
Metabolic disorders: MedlinePlus". Retrieved 27 July 2015. (Accessed December 2017).
Inherited Metabolic Disorders Overview: Overview, Clinical Features and Differential Diagnosis, Epidemiology and Statistics. (Accessed December 2017).
Scotti, L.; Monteiro, A.F.M.; Viana, J.O.; Mendonça Jr., F.J.B.; Ishiki, H.M.; Tchouboun, E.N.; Santos, R.; Scotti, M.T. Multi-target drugs against metabolic disorders. Endocr. Metab. Immune. Disord Drug Targets, 2019. 19(4), 402-418
Singla, R.K.; Dubey, A.K. Phytochemical profiling, gc-ms analysis and α-amylase inhibitory potential of ethanolic extract of Cocos nucifera Linn. Endocarp. Endocr. Metab. Immune Disord. Drug Targets, 2019, 19(4), 419-442.
Khan, H.; Amin, D.; Tewari, D.; Nabavi, S.M.; Atanas, A.G. Plant derived glycosides with α-glucosidase inhibitory activity: Current standing and future prospects. Endocr. Metab. Immune Disord. Drug Targets, 2019, 19(4), 391-401.
Hassan, F.; Qudus, M.S.; Sehgal, S.A.; Ahmed, J.; Khan, M. Haq, K ul; Mumtaz, S.; Arshad, M.; Siraj, S. Prevalence of extended spectrum β-lactamases in multi-drug resistant Pseudomonas aeruginosa from diabetic foot patients. Endocr. Metab. Immune Disord. Drug Targets, 2019, 19(4), 443-448.
Panwar, U.; Singh, S.K. Identification of novel pancreatic lipase inhibitors using structure based virtual screening, docking and simulations studies. Endocr. Metab. Immune Disord. Drug Targets, 2019, 19(4), 449-457.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2019
Page: [389 - 390]
Pages: 2
DOI: 10.2174/187153031904190506102405

Article Metrics

PDF: 16